Autonomous discovery platforms that run closed-loop hypothesis-to-validation cycles. We compress years of drug, materials, protein, and genomics research into weeks.
Trusted by leading research organizations
Our platforms autonomously propose hypotheses, generate candidates, simulate outcomes, and refine results through closed-loop AI cycles.
AI proposes thousands of novel candidates — molecules, materials, or proteins — optimized for your target criteria.
GPU-accelerated simulations evaluate each candidate's properties, binding, stability, and performance in milliseconds.
Multi-objective optimization selects the best candidates and feeds insights back to the generator for the next cycle.
Top candidates are surfaced with full evidence packages, ready for lab synthesis with AI-planned experimental protocols.
Each product is a fully autonomous discovery engine built for a specific scientific domain.
Closed-loop AI drug discovery platform. Autonomously generates drug-like molecules, screens them against protein targets, predicts ADMET properties, and optimizes lead candidates.
AI-native materials discovery platform. Generates novel compositions, predicts properties with physics-informed neural networks 1000x faster than quantum simulations.
AI-powered protein engineering platform. Designs novel proteins, predicts 3D structures in seconds, simulates stability and binding, and optimizes variants through autonomous cycles.
AI-powered genomics and gene therapy platform. Analyzes whole-genome sequences, designs CRISPR guide RNAs, optimizes gene therapy vectors, and predicts variant pathogenicity at scale.
Every Xineplus engagement follows a rigorous path from research objective to prioritized validation package.
Translate scientific goals into measurable design criteria, constraints, and decision thresholds.
Generate, simulate, score, and optimize candidates across hundreds of autonomous cycles.
Inspect ranked candidates with uncertainty, explainability, and protocol recommendations.
Move the strongest candidates into synthesis, assay, or prototype testing with clear handoff data.
GPU-native simulation and inference let teams evaluate orders of magnitude more hypotheses than manual workflows.
Predictions are paired with confidence, provenance, and validation guidance so researchers can make accountable decisions.
Every result feeds the next cycle, improving candidate quality and narrowing the search space continuously.
Find novel scaffolds, rank compounds, and package leads for medicinal chemistry review.
Search electrolyte and electrode composition spaces against conductivity, safety, and cost.
Optimize binding, developability, and humanization before committing to expression.
Design guides, vectors, and variant interpretation workflows for genomic programs.
Xineplus does not hand researchers a black-box score. Each recommendation includes the assumptions, simulations, model confidence, and suggested next experiment.
"XineDiscover compressed our hit identification timeline from 14 months to 3 weeks. The closed-loop optimizer found scaffolds we'd never have explored manually."
"We screened 50,000 alloy compositions in a single week with XineMaterials. Three candidates are now in prototype testing — that would have taken us 2 years traditionally."
"XineProtein's antibody design suite generated 12 high-affinity binders in the first campaign. 4 of them passed all developability filters. That's a 33% hit rate."